Markets.News

UTHR  UNITED THERAPEUTICS CORP

+ add to watchlist

$599.27

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians

Mkt Cap: $25.99B

52 Week High: $607.89

P/E: 15.13

52 Week Low: $266.98

Dividend: $0.00

Shares Outstanding: 43.83M

This news is delayed by 15 minutes, sign up now to get live news & full features.